Island Health is collaborating to conduct research that will help to identify new treatments and diagnostic tests, and improve care for COVID-19 patients, healthcare providers and communities.
Clinical Research
Island Health’s Clinical Trials Unit is working closely with physician investigators, clinical teams, pharmacy and lab to bring new treatments to COVID-19 patients on Vancouver Island. These treatments are only available through clinical trials.
Currently enrolling in BC
Opportunities to participate in clinical trials of investigational treatments for COVID-19 are available for people in BC. Some trials are for people who are experiencing COVID-19 at home (i.e. have not been hospitalized) and have been recently diagnosed.
CONTAIN STUDY – Recruiting adults in BC who have a confirmed diagnosis of COVID-19 within 5 days prior to enrollment in the study.
Four COVID-19 clinical trials are currently underway at Island Health:
- The CATCO (Canadian Treatment of COVID-19) study compares different drug treatments for patients hospitalized with COVID-19.
- The ATTACC study seeks to reduce the risk of blood clot formation in COVID-19 patients.
- The CONCOR-1 study treats hospitalized patients with convalescent plasma from people who have already recovered from COVID-19.
We’re contributing data on COVID-19 symptoms, outcomes and impact to global observational studies like this Short Period Incidence Study of Severe Acute Respiratory Infection. This data is already improving treatment, and will help us plan for future waves.
We’re working with partners to build a Vancouver Island COVID-19 Biobank. The samples in the bank will help researchers find more effective treatments and understand long-term complications.
Learn More
To learn about COVID-19 clinical trial opportunities, sign up through this national portal.
- Research to Support Our Communities
-
We’re collaborating on research that can address urgent needs in our communities by:
Get Involved
